Trial intelligence / Profile preview

Cinnamaldehyde mouthwash for denture stomatitis associated with oral candidiasis

RBR-7zwzs3Phase 2Not yet recruiting

Sponsor
Universidade Federal da Paraíba
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of cinnamaldehyde and miconazole in denture stomatitis (DS) and oral candidiasis (3 arms), sponsored by Universidade Federal da Paraíba. Primary endpoints: Safety and tolerability of cinnamaldehyde mouthwash and Clinical efficacy in denture stomatitis associated with oral candidiasis. Planned start Oct 2019; status: not yet recruiting.

02

Drugs

cinnamaldehydemiconazole
03

Conditions

denture stomatitis (DS)oral candidiasis

Beyond the preview

Go deeper on RBR-7zwzs3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-7zwzs3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call